Matches 151 - 200 out of 299 < 1 2 3 4 5 6 >
Match Document Document Title
5641622 Continuous centrifugation process for the separation of biological components from heterogeneous cell populations  
A method combining the techniques of immunoaffinity separation and continuous flow centrifugal separation is provided for selective separation of a nucleated heterogeneous cell population from a...
5641637 Method of preparing lyophilized and frozen cell standards  
A method is disclosed for preparing lyophilized and frozen cells as cytometry standards.
5635387 Methods and device for culturing human hematopoietic cells and their precursors  
Methods for increasing the number of human hematopoietic precursor cells in vitro are provided. The methods generally comprise (a) separating human hematopoietic precursor cells from mature...
5614490 Administration of low dose hemoglobin to increase perfusion  
This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase...
5612060 Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy  
An improved immunomodulatory therapy for enhancement of depressed host defense mechanisms as shown by improved allograft survival rates is disclosed. The therapy comprises the synergistic...
5601972 Long term storage of red cells in unfrozen solution  
A method for prolonging storage shelf-life of red blood cells under refrigerated conditions includes separating plasma from the red blood cells while retaining residual plasma and adding a...
5599558 Selecting amounts of platelet releasate for efficacious treatment of tissue  
A method of making a platelet releasate product is disclosed involving performing an assay on a platelet releasate sample for a component of the releasate and forming platelet releasate product by...
5595735 Hemostatic thrombin paste composition  
A hemostatic paste composition comprising a hemostatic effective amount of thrombin in a polyethylene glycol base which is preferably prepared by admixing an aqueous solution of thrombin and...
5580779 Method for inducing human myocardial cell proliferation  
The present invention relates to a method for inducing myocardial cell proliferation. It is based, at least in part, on the discovery that adult human myocardial cells may be induced to proliferate...
5580781 Three-dimensional tumor cell and tissue culture system  
The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance...
5578326 Method and an apparatus for preparing tissue repair promoting substances  
A method for isolating tissue repair promoting substances from human or animal blood, which method comprises collecting the human or animal blood from a single human or animal individual in a first...
5567443 Method of treating inflammatory diseases  
A method of treating inflammatory diseases, in which peripheral blood of a patient suffering from an inflammatory disease is made into contact with a carrier whose affinity for...
5563120 Cytokine preparation for immunotherapy  
A cytokine composition is prepared for use in immunotherapy of various diseases. The composition is prepared by culturing leucocytes previously infected with a virus in a culture medium containing...
5560935 Physiologically active substances extracted from activated tissues  
The present invention provides a physiologically active substance which inhibits plasma kallikrein production, improves peripheral blood flow, and exhibits analgesic, antiinflammatory and...
5545516 Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light  
This invention provides methods for inactivating pathogenic contaminants in whole blood, plasma, cellular blood components, or in any combination thereof, by adding a phenthiazin-5-ium dye(s)...
5506112 Reagent used for determining factor VIII activity  
To determine the factor VIII activity of a sample, the latter is reacted with a reagent containing thrombin, factor IXaβ, phospholipids and calcium ions so as to form a factor VIIIa-factor...
5487971 Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets  
The invention is a sterile, plasma-free storage medium for blood components including red blood cells and for platelets processed separately or together. The red cell storage medium includes...
5480773 Method for preserving blood using ascorbic acid tocopheryl phosphate esters  
A method for the preservation of blood and a blood preserving composition comprising a phosphoric acid diester of the following formula: ##STR1## (wherein R 1 and R 2 are the same or different...
5443984 Method for culturing mammalian cells in a medium containing fish serum  
A method for culturing mammalian cells using fish serum. The method uses serum extracted from the blood of fishes to culture mammalian cells for various purposes. The technique has the key...
5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use  
Oil and water emulsions containing alkylphosphoryl choline or alkylglycerophosphoryl choline surfactants are disclosed. The surfactants have the following general structures: ##STR1## In the above...
5432058 Method for measuring human cholesterol absorption using metabolically stable isotopes  
This invention is a method for measuring the ability of a human to absorb cholesterol. The method uses two different cholesterol tracers, the first injected into the blood stream and the second...
5425951 Method of reconstituting lyophilized cells  
A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to...
5422393 Natriuretic hormone  
A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a...
5409827 Blended bovine sera cellular growth media and their methods of production and use  
The present invention provides media and methods for the maintenance or promotion of growth of a cellular line, particularly a hybridoma cellular line. A serum blend is disclosed comprising fetal...
5407673 Fibrinolysis and fibrinogenolysis treatment  
Disclosed is a fibrinolysis and fibrinogenolysis treatment which includes parenterally introducing into the body of a human patient human plasmin in fibrinolytically and fibrinogenolytically active...
5397578 Method of treatment of chronic purulent inflammations of ear in children  
A method for treating chronic, purulent, middle otitis in children, comprising administering, through a perforation into a middle ear cavity, a freshly prepared donor plasma of one of the parents...
5332578 Platelet membrane microparticles  
A heat-treated, viral-inactivated platelet membrane microparticle product is provided. The microparticles may be prepared from outdated mammalian platelets. The microparticle product contains...
5318782 Method for preparing tissue repair promoting substances  
A method for isolating tissue repair promoting substances from human or animal blood, which method comprises collecting the human or animal blood from a single human or animal individual in a first...
5309723 Method of freezing red blood cells  
A method of freezing a standard donor unit of red blood cells such that it can be stored for long periods and subsequently recovered in a form pure enough for transfusion purposes involves...
5304325 Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use  
Oil and water emulsions containing alkylphosphoryl choline or alkylglycerophosphoryl choline surfactants are disclosed. The surfactants have the following general structures: ##STR1## In the above...
5296467 Composition comprising an anticoagulant  
Pharmaceutical compositions which consist essentially of a vascular anticoagulant annexine, Ca 2 +, Zn 2 +, and a pharmaceutically acceptable carrier are disclosed. Also disclosed are processes for...
5294544 Biologically active factor  
The invention comprises a factor having the following characteristics: a) It inhibits granulocyte-macrophage colony and cluster formation; b) It has a molecular weight of about 8 kDa as...
5277915 Gel-in-matrix containing a fractured hydrogel  
A three dimensional porous matrix, such as a reticulated open-cell foam, having within its matrix structure a mechanically-fractured hydrogel containing a network of fracture channels. The...
5250303 Procedure for storing red cells with prolonged maintenance of cellular concentrations of ATP and 2,3 DPG  
This invention provides an improved method for prolonging the shelf life of transfusible red blood cells by decreasing the effective osmolality of the suspending solution and increasing the...
5240714 Non-digoxin-like Na.sup.+, K.sup.+ -ATPase inhibitory factor  
A highly purified, Na + ,K + -ATPase inhibitory factor is disclosed herein. The factor does not cross-react with anti-digoxin antibody and exhibits uniquely characteristic UV absorbance maxima at...
5232844 Photodynamic inactivation of viruses in cell-containing compositions  
The present invention concerns the product produced by inactivating extracellular lipid enveloped pathogenic virus or intracellular pathogenic virus in a composition containing >1×10 9 ...
5214033 Factor VIII coagulant polypeptides  
Fragments of the factor VIII:C polypeptide have been discovered which exhibit highly specific factor VIII activity. Monoclonal antibodies to the polypeptide fragments and methods for the isolation...
5213813 Pyridoxal-5'-phosphate as an in vitro blood platelet stabilizer  
The use of pyridoxal-5'-phosphate as an in vitro anticoagulant agent which retains the platelet activity of stored whole blood or stored plasma for more than about six hours is disclosed.
5200199 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Method for preparing tissue repair promoting substances  
A method for isolating tissue repair promoting substances from human or animal blood which comprises collecting the human or animal blood from a single human or animal individual in a first...
5199942 Method for improving autologous transplantation  
There is disclosed a method for autologous hematopoietic cell transplantation of patients receiving cytoreductive therapy, comprising: (1) obtaining hematopoietic progenitor cells from bone marrow...
5186945 Blood plasma antiviral process and composition  
The treatment of blood plasma to inactivate or destroy infective viruses, such as the cytomegalovirus CMV, by mixing the plasma with an effective amount of glycyrrhizic triterpenoid compounds is...
5178884 Lyophilized and reconstituted red blood cell compositions  
A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible amphipathic...
5149540 Thrombin composition for oral administration  
A stable thrombin composition for oral administration having an excellent solubility is prepared with thrombin as a hemostatic ingredient, gelatin, albumin and glycine as a stabilizer and sucrose...
5128150 Albumin enhanced antiviral blood product treatment and product produced  
The treatment of blood product to inactivate or destroy infective viruses found in animal fluids and tissues, such as the cytomegalovirus, by mixing the blood product with an effective amount of...
5128149 Enhanced blood product antiviral process and product produced  
A transfusion blood product container for the introduction of one or more blood products, such as whole blood, platelet concentrations, leukocyte concentrations, plasma, phasma derivatives, whole...
5108760 Enhances LAK cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides  
There is provided an improved process for enhanced LAK cell activation wherein the peripheral blood mononuclear cells are treated with an amino acid amide to yield depletion, prior to the...
5106833 Coagulation inhibitors  
Novel blood coagulation inhibitors are disclosed which are peptide fragments comprising (A) Kunitz-type domain two of lipoprotein-associated coagulation inhibitor which inhibits Factor Xa...
5091363 Agent for the therapy of factor VIII-resistant hemophilia A, and a process for the preparation thereof  
An agent for the therapy of hemophilia A which is resistant to treatment with factor VIII is described, and is obtainable by maintaining a mixture of factor VIII, antithrombin III, a phospholipid...
5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof  
A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of...
5055485 Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides  
A process of inactivating infectious viruses in a cell-containing or a protein-containing composition containing such viruses, comprising contacting such composition with an effective amount of at...
Matches 151 - 200 out of 299 < 1 2 3 4 5 6 >